Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CTI BioPharma Corp. (CTIC)

4.2   0.54 (14.75%) 05-16 08:00
Open: 4.01 Pre. Close: 3.66
High: 4.67 Low: 3.95
Volume: 8,298,855 Market Cap: 424(M)
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.67 - 4.7 4.7 - 4.73
Low: 3.9 - 3.92 3.92 - 3.94
Close: 4.16 - 4.2 4.2 - 4.24

Technical analysis

as of: 2022-05-16 7:47:15 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.64     One year: 6.72
Support: Support1: 3.32    Support2: 2.76
Resistance: Resistance1: 4.82    Resistance2: 5.76
Pivot: 4.7
Moving Average: MA(5): 3.91     MA(20): 4.75
MA(100): 3.47     MA(250): 2.92
MACD: MACD(12,26): -0.2     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 28.5     %D(3): 18.7
RSI: RSI(14): 44.8
52-week: High: 5.76  Low: 1.42
Average Vol(K): 3-Month: 6,488 (K)  10-Days: 4,578 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CTIC ] has closed above bottom band by 31.4%. Bollinger Bands are 126.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Headline News

Mon, 16 May 2022
Bloomington Symphony Orchestra celebrates 'The Planets' Gala-ctic way - The Herald-Times

Fri, 13 May 2022
Should You Buy CTI BioPharma Corp (CTIC) Stock Friday Morning? - InvestorsObserver

Tue, 10 May 2022
CTI BioPharma Announces Presentation at the 2022 American Society of Clinical Oncology Annual Meeting - Yahoo Finance

Fri, 06 May 2022
Comparing Arrowhead Pharmaceuticals (NASDAQ:ARWR) & CTI BioPharma (NASDAQ:CTIC) - Defense World

Wed, 04 May 2022
CTI BioPharma Stock Is A Strong Buy (NASDAQ:CTIC) - Seeking Alpha

Fri, 29 Apr 2022
$30.90 Million in Sales Expected for CTI BioPharma Corp. (NASDAQ:CTIC) This Quarter - Defense World

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 101 (M)
Shares Float 74 (M)
% Held by Insiders 0.2 (%)
% Held by Institutions 50.2 (%)
Shares Short 10,130 (K)
Shares Short P.Month 8,320 (K)

Stock Financials

EPS -1.1
EPS Est Next Qtl 0
EPS Est This Year -1.26
EPS Est Next Year -1.88
Book Value (p.s.) 0.03
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -91.4
Return on Equity (ttm) -447.2
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.95
Qtrly Earnings Growth 0
Operating Cash Flow -85 (M)
Levered Free Cash Flow -49 (M)

Stock Valuations

PE Ratio -3.86
PEG Ratio 0
Price to Book value 105
Price to Sales 0
Price to Cash Flow -5

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2017-01-02
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.